Loading provider…
Loading provider…
Neurology Physician in Rochester, NY
NPI: 1558386623Primary Practice Location
STRONG MEMORIAL HOSPITAL
601 Elmwood Ave, Rochester, NY
Primary Employer
Strong Memorial Hospital MD Group
urmc.rochester.edu
HQ Phone
Get MD David's Phone Numberphone_androidMobile
Get MD David's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
University of Michigan Health System
fellowship • Clinical Neurophysiology
1998 - 1999
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 88342Tissue or cell analysis by immunologic technique | 36 | 71 |
| 2 | 88313Special stained specimen slides to examine tissue including interpretation and report | 36 | 73 |
| 3 | 88305Pathology examination of tissue using a microscope, intermediate complexity | 36 | 72 |
| 4 | 88356Microscopic genetic analysis of nerve tissue | 35 | 71 |
| 5 | 99215Established patient office or other outpatient, visit typically 40 minutes | 26 | 26 |
Granulomatous myositis, primary biliary cirrhosis, pancytopenia, and thymoma.
Authors: Eva Feldman
Journal: Muscle Nerve
Rydel-Seiffer fork revisited: Beyond a simple case of black and white.
Electrodiagnostic consultations in Zambia: Referral characteristics and neuromuscular disorders.
Authors: Michael Andary, Michelle Kvalsund, Gretchen Birbeck
Journal: J Neurol Sci
Publication Date: 2018-12-04
Lead Sponsor: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
Intervention / Treatment: DRUG: Placebo, DRUG: ACE-083
Lead Sponsor: University of Iowa
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS), University of Rochester, University of South Florida, Muscular Dystrophy Association, Charcot-Marie-Tooth Association
Lead Sponsor: Virginia Commonwealth University
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS), NeuroNEXT Network
Intervention / Treatment: OTHER: Placebo, DRUG: topiramate